TMEM97 as a new therapeutic target for the treatment of neuropathic pain
Jan. 16, 2024
The σ2 receptor (σ2R) has been recently identified as transmembrane protein 97 (TMEM97), and ligands of σ2R/TMEM97 have previously shown the ability to alleviate mechanical hypersensitivity in mouse models of neuropathic pain.